Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the United States Antacid market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Antacids are a type of medicine that is taken to neutralize stomach acid and is usually used to alleviate heartburn, stomach pain, indigestion, nausea, or an upset stomach due to acid reflux. Antacids can be administered by mouth or by a pump. Some antacids are available over the counter, while others are prescribed by physicians. Generally, the more common types of antacids sold over the counter include aluminum hydroxide, calcium carbonate, calcium phosphate, calcium oxalate, magnesium hydroxide, sodium bicarbonate, and stearic acid. Other antacids that are available by prescription include magnesium sulfate, prilosec, and trihalomethanes (THMs).
Growing prevalence of Gastro-Esophageal Reflux Diseases (GERD) is a prime factor driving growth of the antacids market. According to the Gut journal, published by the International Foundation for Gastrointestinal Disorders; in 2017, the prevalence of GERD was around 18% to 28% in North America, 9% to 26% in Europe, 3% to 8% in East Asia, 9% to 33% in the Middle East, 12% in Australia, and 23% in South America. Moreover, the increasing prevalence of heartburn cases as it is one of the major causes of acid production in the stomach is again expected to augment growth of the market. Furthermore, growing number of retail pharmacies is further anticipated to propel growth of the market. For example, MedPlus has around 1,400 outlets out of which 1,350 are self-owned and the rest are taken as a franchisee. Also, expanding online pharmacy is another major key factor stimulating growth of the market.
The U.S is accounted for the presence of well-established healthcare infrastructure, high prevalence of hyperacidity, and growing pharma companies. According to a new Cedars-Sinai study, more than a third of U.S. adults might experience acid reflux every week.
Key Developments:
- In April 2019, Abbott announced the launch of a campaign to address today's hyperacidity woes in India.
- In January 2019, Northwell Health launches a trial testing antacid drug histamine 2 blocker famotidine as a potential COVID-19 treatment
- In October 2019, Strides Pharma Science has resumed sales of batches of Ranitidine tablets in the Australia market as it has received a green signal from the country's regulatory body Therapeutic Goods Administration (TGA)
- In February 2021, GSK Consumer Healthcare has announced the launch of TUMS Naturals, a new naturally-powered antacid in India.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antacid in these regions, from 2018 to 2025 (forecast).
United States Antacid market competition by top manufacturers/players, with Antacid sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
TUMS
Medique
Medline Industries
Prakash
GSK
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Adult
Pediatric
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antacid for each application, including
Hospital
Clinic
Medical Center
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Antacid Market Report 2019
1 Antacid Overview
1.1 Product Overview and Scope of Antacid
1.2 Classification of Antacid by Product Category
1.2.1 United States Antacid Market Size (Sales Volume) Comparison by Type (2014-2024)
1.2.2 United States Antacid Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Adult
1.2.4 Pediatric
1.3 United States Antacid Market by Application/End Users
1.3.1 United States Antacid Market Size (Consumption) and Market Share Comparison by Application (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Others
1.4 United States Antacid Market by Region
1.4.1 United States Antacid Market Size (Value) Comparison by Region (2014-2024)
1.4.2 The West Antacid Status and Prospect (2014-2024)
1.4.3 Southwest Antacid Status and Prospect (2014-2024)
1.4.4 The Middle Atlantic Antacid Status and Prospect (2014-2024)
1.4.5 New England Antacid Status and Prospect (2014-2024)
1.4.6 The South Antacid Status and Prospect (2014-2024)
1.4.7 The Midwest Antacid Status and Prospect (2014-2024)
1.5 United States Market Size (Value and Volume) of Antacid (2014-2024)
1.5.1 United States Antacid Sales and Growth Rate (2014-2024)
1.5.2 United States Antacid Revenue and Growth Rate (2014-2024)
2 United States Antacid Market Competition by Players/Suppliers
2.1 United States Antacid Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Antacid Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Antacid Average Price by Players/Suppliers (2014-2019)
2.4 United States Antacid Market Competitive Situation and Trends
2.4.1 United States Antacid Market Concentration Rate
2.4.2 United States Antacid Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antacid Manufacturing Base Distribution, Sales Area, Product Type
3 United States Antacid Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Antacid Sales and Market Share by Region (2014-2019)
3.2 United States Antacid Revenue and Market Share by Region (2014-2019)
3.3 United States Antacid Price by Region (2014-2019)
4 United States Antacid Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Antacid Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Antacid Revenue and Market Share by Type (2014-2019)
4.3 United States Antacid Price by Type (2014-2019)
4.4 United States Antacid Sales Growth Rate by Type (2014-2019)
5 United States Antacid Sales (Volume) by Application (2014-2019)
5.1 United States Antacid Sales and Market Share by Application (2014-2019)
5.2 United States Antacid Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Antacid Players/Suppliers Profiles and Sales Data
6.1 TUMS
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antacid Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 TUMS Antacid Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Medique
6.2.2 Antacid Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Medique Antacid Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Medline Industries
6.3.2 Antacid Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medline Industries Antacid Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Prakash
6.4.2 Antacid Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Prakash Antacid Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 GSK
6.5.2 Antacid Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GSK Antacid Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
...
7 Antacid Manufacturing Cost Analysis
7.1 Antacid Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antacid
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antacid Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antacid Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Antacid Market Size (Value and Volume) Forecast (2019-2024)
11.1 United States Antacid Sales Volume, Revenue Forecast (2019-2024)
11.2 United States Antacid Sales Volume Forecast by Type (2019-2024)
11.3 United States Antacid Sales Volume Forecast by Application (2019-2024)
11.4 United States Antacid Sales Volume Forecast by Region (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
